Patents

Biothera’s superior intellectual property and dominant patent position provides customers with confidence in the safety, efficacy and long-term availability of the company's products. Biothera has more than 40 U.S. patents and patents pending, with additional filings in more than 20 countries that protect:

• Matter of composition

• Manufacturing processes

• Applications

Biothera has successfully defended its patents in U.S. courts against infringement. The company intends to continue to vigorously protect its intellectual property rights.